Abstract
The plasma peak, trough, and peak-trough concentrations of netilmicin given to preterm and term infants were measured after different regimens to determine which dosage would provide satisfactory peak and trough concentrations. In infants aged less than 7 days, dosage regimens of 3.0 or 2.5 mg/kg every 12 hours gave satisfactory peak levels (range 5.2-12.0 micrograms/ml) but troughs were above the desirable maximum level of 3 micrograms/ml in more than half the preterm infants. Subsequently a dosage regimen of 3.0 mg/kg immediately followed by 2.0 mg/kg every 12 hours resulted in trough levels that exceeded 3 micrograms/ml in only 2 of 25 preterm determinations and never in term infants, yet gave satisfactory peak levels (range 4.5-7.4 micrograms/ml). In preterm infants aged 4 to 7 weeks a dosage of 3 mg/kg every 8 hours gave satisfactory peak and trough levels.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bowman R. L., Silverblatt F. J., Kaloyanides G. J. Comparison of the nephrotoxicity of netilmicin and gentamicin in rats. Antimicrob Agents Chemother. 1977 Oct;12(4):474–478. doi: 10.1128/aac.12.4.474. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Brook I. Tolerance and efficacy of netilmicin in pediatric patients with gram-negative pneumonia. Chemotherapy. 1980;26(6):452–460. doi: 10.1159/000237942. [DOI] [PubMed] [Google Scholar]
- Chindasilpa V., Schauf V., Hamilton L. R., Riff L. J. Netilmicin use in pediatric patients. Dev Pharmacol Ther. 1980;1(4):238–253. [PubMed] [Google Scholar]
- Miller G. H., Arcieri G., Weinstein M. J., Waitz J. A. Biological activity of netilmicin, a broad-spectrum semisynthetic aminoglycoside antibiotic. Antimicrob Agents Chemother. 1976 Nov;10(5):827–836. doi: 10.1128/aac.10.5.827. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Milner R. D., Ross J., Froud D. J., Davis J. A. Clinical pharmacology of gentamicin in the newborn infant. Arch Dis Child. 1972 Dec;47(256):927–932. doi: 10.1136/adc.47.256.927. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Peitersen B., Hørlyk H., Nielsen M., Prag J., Korner B., Heilesen A. M., Friis-Møller A. Netilmicin: efficacy and tolerance in the treatment of systemic infections in neonates. Scand J Infect Dis Suppl. 1980;Suppl 23:151–154. [PubMed] [Google Scholar]
- Riff L. J., Moreschi G. Netilmicin and gentamicin: comparative pharmacology in humans. Antimicrob Agents Chemother. 1977 Apr;11(4):609–614. doi: 10.1128/aac.11.4.609. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Riff L., Schauf V. Use of aminoglycosides in the neonate. Semin Perinatol. 1982 Apr;6(2):155–165. [PubMed] [Google Scholar]
- Siegel J. D., McCracken G. H., Jr, Thomas M. L., Threlkeld N. Pharmacokinetic properties of netilmicin in newborn infants. Antimicrob Agents Chemother. 1979 Feb;15(2):246–253. doi: 10.1128/aac.15.2.246. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Trujillo H., Manotas R., Loaiza J. Safety and efficacy of netilmicin in neonates with serious systemic infections. J Int Med Res. 1981;9(1):52–57. doi: 10.1177/030006058100900109. [DOI] [PubMed] [Google Scholar]